US President Donald Trumpâs latest 90-day pause on tariffs on all nations except China should come as a breather for Indian pharma stocks. The Nifty Pharma index is down about 5% from its close on 2 April versus 4% drop in Nifty50. While pharma was exempted initially, Trumpâs subsequent statements point out that the pharma…
New Delhi: Small pharma companies can file an online application if they want to take one more year to comply with global good manufacturing practices (GMPs), the Drugs Controller General of India (DCGI) said. The application has to be submitted through the Online National Drugs Licensing System (ONDLS) portal as no hard copy application will…
New Delhi: A total of 103 applications have been approved for Central financial assistance to MSME (micro, small and medium enterprises) drug firms wishing to upgrade to international standards, the government said, addressing an impediment to Indiaâs pharma export ambitions. The total financial support under the governmentâs revamped Pharmaceutical Technology Upgradation Assistance Scheme amounted to…
